Stock Analysis of Wal-Mart and Johnson & Johnson

Wal-Mart Full Company Profile

Johnson & Johnson has around 115,500 employees worldwide helping in the research and sale of many products in the health care field. The company has businesses all over the world. The Consumer segment of the business includes many products used in baby care, skin care, oral care, wound care, women’s health care, and nutritional and over-the-counter pharmaceutical products. These are all sold to the general public.   The Pharmaceutical segment has products in therapeutic areas such as anti-infective, antipsychotic, cardiovascular, contraceptive, dermatology, and immunology. These products are sold to retailers and healthcare professionals for prescription use all over the world. The Medical Devices and Diagnostics segment has many products used in the professional fields by physicians, therapists, hospitals, diagnostic labs, and clinics. For example, there are spinal care and sports medicine products, aesthetics and women’s health products, and invasive surgical products. Also, around 25% of these sales go into research and development.
During 2009, Johnson & Johnson delivered a total shareholder return of 11.3 percent.
They are also planning to help impoverished countries improve their healthcare. Johnson & Johnson is sending experienced healthcare professionals over to countries such as Russia to help train them on better and more efficient ways of performing surgeries such as removing cysts. Therefore Johnson & Johnson is hoping to improve conditions all over the world. They also do extensive research on women’s health issues, and have recently even had breakthroughs in making breast reconstruction much easier. Also, they help fund   Biosense Webster, Inc. and The Cellsearch System helping to fund more research in the cause of strokes and how to treat them as well as finding cures for cancer. Also, new product lines and new markets for existing products continue to provide growth opportunities for the company....